Author:
Abbas Sameen,Khan Amjad,Akhtar Tayyab Saeed,Samad Abdul,Chinnam Sampath,Mushtaq Saima,Usman Muhammad,Khan Arshad,Akash Muhammad Sajid Hamid
Publisher
Springer Nature Singapore
Reference141 articles.
1. Ahmed MM, Khalil KA, Eida MM, Salem A (2022) Effect of fecal microbiota transplant versus conventional medications in treatment of irritable bowel syndrome. Afro-Egyptian J Infect Endem Dis (Internet) 12(3):218–230. https://aeji.journals.ekb.eg/article_246991.html
2. Alagiakrishnan K, Halverson T (2021) Holistic perspective of the role of gut microbes in diabetes mellitus and its management. World J Diabetes 12(9):1463
3. Alexea O, Bacarea V, Piqué N (2016) The combination of oligo-and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial. United Eur Gastroenterol J 4(3):455–465
4. Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43(3):246–252
5. Aroniadis OC, Brandt LJ (2014) Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol Hepatol (NY) 10(4):230